ArticlePLOS digital health2026
Machine learning based classification of aggressive and malignant renal tumors from multimodal data.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epidemiological Trends and Burden of Adult Kidney Cancer in Saudi Arabia: A 42-Year Retrospective Analysis (1982-2023).Cancer reports (Hoboken, N.J.) · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to develop and evaluate a machine learning pipeline using multiphase contrast-enhanced CT images and clinical data to classify renal tumors as benign, malignant-indolent, or malignant-aggressive, while assessing the contribution of each data source to the classification. In this retrospective study, 448 patients (mean age: 60.7 ± 12.6 years, 306 male, 142 female) who underwent nephrectomy and preoperative CECT between June 2008 and July 2018 were included. Tumors were histologically categorized as benign-indolent, malignant-indolent, or malignant-aggressive. Self-supervised feature extraction converted 4-phase CECT images into 512 real-valued features, combined with clinical data and tumor size for classification. Two machine learning classifiers, random forest (RF) and multi-layer perceptron (MLP), were used to predict tumor type. Nested five-fold cross-validation was employed for hyperparameter tuning and model evaluation, and performance was assessed using area under the curve (AUC) analysis. The best-performing models achieved an AUC of 0.90 (95% CI: 0.88-0.93) for classifying indolent versus aggressive tumors and 0.76 (95% CI: 0.71-0.81) for malignant versus benign tumors. Models incorporating tumor size significantly improved classification accuracy. RF classifiers excelled in distinguishing indolent from aggressive tumors, while MLP classifiers performed better for malignant versus benign classification. The machine learning pipeline demonstrated high accuracy in differentiating aggressive from indolent renal tumors, offering valuable prognostic insights for personalized treatment. Tumor size was a critical factor, complementing CECT images and clinical data. These findings highlight the potential of ML techniques in enhancing renal tumor risk stratification.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.